» Articles » PMID: 36685063

Optimizing Repair of Tendon Ruptures and Chronic Tendinopathies: Integrating the Use of Biomarkers with Biological Interventions to Improve Patient Outcomes and Clinical Trial Design

Overview
Date 2023 Jan 23
PMID 36685063
Authors
Affiliations
Soon will be listed here.
Abstract

Tendons are dense connective tissues of the musculoskeletal system that link bones with muscles to foster mobility. They have complex structures and exist in varying biomechanical, metabolic and biological environments. In addition, tendon composition and mechanical properties can change over the lifespan as an individual ages. Many tendons function in high stress conditions with a low vascular and neuronal supply, conditions often leading to development of chronic tendinopathies, and in some cases, overt rupture of the tissues. Given their essential nature for human mobility and navigation through the environment, the effective repair and regeneration of different tendons after injury or damage is critical for quality of life, and for elite athletes, the return to sport participation at a high level. However, for mainly unknown reasons, the outcomes following injury are not always successful and lead to functional compromise and risk for re-injury. Thus, there is a need to identify those patients who are at risk for developing tendon problems, as well those at risk for poor outcomes after injury and to design interventions to improve outcomes after injury or rupture to specific tendons. This review will discuss recent advances in the identification of biomarkers prognostic for successful and less successful outcomes after tendon injury, and the mechanistic implications of such biomarkers, as well as the potential for specific biologic interventions to enhance outcomes to improve both quality of life and a return to participation in sports. In addition, the implication of these biomarkers for clinical trial design is discussed, as is the issue of whether such biomarkers for successful healing of one tendon can be extended to all tendons or are valid only for tendons in specific biomechanical and biological environments. As maintaining an active lifestyle is critical for health, the successful implementation of these advances will benefit the large number of individuals at risk.

Citing Articles

Optimizing tendon repair and regeneration: how does the environment shape outcomes following rupture of a tendon such as the Achilles tendon?.

Hart D, Ahmed A, Chen J, Ackermann P Front Bioeng Biotechnol. 2024; 12:1357871.

PMID: 38433820 PMC: 10905747. DOI: 10.3389/fbioe.2024.1357871.

References
1.
Itro A, Trotta M, Miranda R, Paoletta M, De Cicco A, Lepre C . Why Use Adipose-Derived Mesenchymal Stem Cells in Tendinopathic Patients: A Systematic Review. Pharmaceutics. 2022; 14(6). PMC: 9230128. DOI: 10.3390/pharmaceutics14061151. View

2.
Scott A, Lian O, Bahr R, Hart D, Duronio V . VEGF expression in patellar tendinopathy: a preliminary study. Clin Orthop Relat Res. 2008; 466(7):1598-604. PMC: 2505256. DOI: 10.1007/s11999-008-0272-x. View

3.
Xu T, Lin Y, Yu X, Jiang G, Wang J, Xu K . Comparative Effects of Exosomes and Ectosomes Isolated From Adipose-Derived Mesenchymal Stem Cells on Achilles Tendinopathy in a Rat Model. Am J Sports Med. 2022; 50(10):2740-2752. DOI: 10.1177/03635465221108972. View

4.
Bray C, Walker C, Spence D . Orthobiologics in Pediatric Sports Medicine. Orthop Clin North Am. 2017; 48(3):333-342. DOI: 10.1016/j.ocl.2017.03.006. View

5.
Almeria C, Kress S, Weber V, Egger D, Kasper C . Heterogeneity of mesenchymal stem cell-derived extracellular vesicles is highly impacted by the tissue/cell source and culture conditions. Cell Biosci. 2022; 12(1):51. PMC: 9063275. DOI: 10.1186/s13578-022-00786-7. View